Biotech Shares Soar Premarket On Sale Of R&D Assets
30 Janeiro 2024 - 11:25AM
AllPennyStocks.com
A Massachusetts-based biotech company is
stealing the show so far during Tuesday’s premarket hours after it
was announced that the company has agreed to sell its pipeline
of...
To read the full story on AllPennyStocks.com, click
here.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024